Fujian Aonong Biological Technology Grouporp (SHSE:603363) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603363 Fujian Aonong Biological Technology Group Incorp Ltd SHSE:603363
31 GF Score
Price ¥2.67
GF Value ¥1.32
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Fujian Aonong Biological Technology Grouporp Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Fujian Aonong Biological Technology Grouporp Valuation Rank Related Terms

SHSE:603363
31GF Score
Fujian Aonong Biological Technology Group Incorp Ltd SHSE:603363
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fujian Aonong Biological Technology Grouporp (SHSE:603363) Overvalued in 2026?

Based on GuruFocus' analysis, Fujian Aonong Biological Technology Grouporp stock appears to be overvalued. The current stock price of ¥2.67 is trading 102.3% above its estimated GF Value™ of ¥1.32. GuruFocus considers Fujian Aonong Biological Technology Grouporp to be Significantly Overvalued.

Key valuation signals for SHSE:603363:

  • Valuation Rank:
  • GF Value™: ¥1.32 vs. price of ¥2.67 (102.3% above fair value)
  • GF Score™: 31/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fujian Aonong Biological Technology Grouporp Business Description

Address Guanyinshan Operation Center, 12th Floor, Building 10, Siming District, Fujian Province, Xiamen, CHN, 361008
Fujian Aonong Biological Technology Group Incorp Ltd is an agricultural and animal husbandry enterprise in China. The principal business activities of the company include feed-oriented service, animal protection, pig raising, and raw material trade. In addition, the company's insurance business mainly relies on the feed marketing system throughout the country to provide downstream farmers with relevant products for disease prevention and control.
31GF Score

Get the complete analysis for SHSE:603363

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥2.67
Price
¥1.32
GF Value